AREDS2 AGE-RELATED EYE DISEASE STUDY 2 Trademark

Trademark Overview

On Wednesday, May 9, 2007, a trademark application was filed for AREDS2 AGE-RELATED EYE DISEASE STUDY 2 with the United States Patent and Trademark Office. The USPTO has given the AREDS2 AGE-RELATED EYE DISEASE STUDY 2 trademark a serial number of 77176528. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, June 20, 2018. This trademark is owned by U.S. Department of Health and Human Services. The AREDS2 AGE-RELATED EYE DISEASE STUDY 2 trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research of the effects of pharmacologic doses of dietary supplements on age-related macular degeneration and cataract; scientific research of the clinical course, prognosis and risk factors of age-related macular degeneration and cataract; providing information related to scientific research of the effects of pharmacologic doses of dietary supplements on age-related macular degeneration and cataract and scientific research of the clinical course, prognosis and risk factors of age-related macular degeneration and cataract
areds2 age-related eye disease study 2

General Information

Serial Number77176528
Word MarkAREDS2 AGE-RELATED EYE DISEASE STUDY 2
Filing DateWednesday, May 9, 2007
Status800 - REGISTERED AND RENEWED
Status DateWednesday, June 20, 2018
Registration Number3574539
Registration DateTuesday, February 17, 2009
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 4, 2007

Trademark Statements

Description of MarkThe mark consists of a fanciful representation of an eye shown as two overlapping images.
Pseudo MarkAREDS TWO AGE-RELATED EYE DISEASE STUDY TWO
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"AGE-RELATED EYE DISEASE STUDY 2"
Goods and ServicesScientific research of the effects of pharmacologic doses of dietary supplements on age-related macular degeneration and cataract; scientific research of the clinical course, prognosis and risk factors of age-related macular degeneration and cataract; providing information related to scientific research of the effects of pharmacologic doses of dietary supplements on age-related macular degeneration and cataract and scientific research of the clinical course, prognosis and risk factors of age-related macular degeneration and cataract

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 14, 2007
Primary Code042
First Use Anywhere DateMonday, January 1, 2007
First Use In Commerce DateMonday, January 1, 2007

Trademark Owner History

Party NameU.S. Department of Health and Human Services
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBethesda, MD 208922111
Party NameU.S. Department of Health and Human Services
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBethesda, MD 208927181
Party NameU.S. Department of Health and Human Services
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBethesda, MD 208927181

Trademark Events

Event DateEvent Description
Wednesday, October 26, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 26, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 26, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, October 26, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 26, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 26, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 20, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, June 20, 2018REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, June 20, 2018REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, June 20, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, June 8, 2018TEAS SECTION 8 & 9 RECEIVED
Saturday, February 17, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, September 30, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, September 30, 2014REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, September 30, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, September 23, 2014TEAS SECTION 8 & 15 RECEIVED
Monday, June 29, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 29, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 17, 2009REGISTERED-PRINCIPAL REGISTER
Thursday, January 15, 2009NOTICE OF ALLOWANCE CANCELLED
Tuesday, January 6, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 17, 2008EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Friday, June 6, 2008APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 5, 2008PAPER RECEIVED
Thursday, December 13, 2007EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, December 4, 2007PUBLISHED FOR OPPOSITION
Wednesday, November 14, 2007NOTICE OF PUBLICATION
Saturday, October 27, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, October 27, 2007ASSIGNED TO LIE
Wednesday, September 26, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 20, 2007EXAMINER'S AMENDMENT ENTERED
Thursday, September 20, 2007NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, September 20, 2007EXAMINERS AMENDMENT E-MAILED
Thursday, September 20, 2007EXAMINERS AMENDMENT -WRITTEN
Friday, September 7, 2007NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 7, 2007NON-FINAL ACTION E-MAILED
Friday, September 7, 2007NON-FINAL ACTION WRITTEN
Wednesday, August 22, 2007ASSIGNED TO EXAMINER
Tuesday, May 15, 2007NOTICE OF DESIGN SEARCH CODE MAILED
Monday, May 14, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

study disease related areds scientific cataract degeneration macular research course prognosis risk factors